Immunovant: TED Data Sets Stage For Batoclimab Regulatory Filings Going Forward
Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...
GlobalData on MSN19h
Immunovant will not seek approval for MG therapy, despite hitting endpoints
The company plans to use results from its Phase III myasthenia gravis study to support its pipeline candidate IMVT-1402 over ...
Immunovant's muscle drug meets main goal, shares gain on new drug promise
Immunovant said on Wednesday its experimental treatment for a type of chronic muscle weakness improved patients' symptoms and that it aimed to use the data to accelerate the development of a newer ...
Investor's Business Daily on MSN16h
Roivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rose.
Immunovant and Roivant Sciences said Wednesday their rare disease drug succeeded in a final-phase study, but the duo won't seek approval.
Medscape2h
Chikungunya Vaccine Shows Strong Immune Response in Prior Recipients of Alphavirus Vaccine
The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...